<p> Greensignal Bio Product Note Pharma Limited Public Issue of Equity Shares</p><p>Offer Size: Up to 1,45,79,560 Equity Shares O f f e r</p><p>B r e a k</p><p> u p :</p><p>Greensignal Bio Pharma Limited is one of the four companies worldwide who have been WHO-prequalified to supply the BCG vaccine to UNICEF. And has secured a long term arrangement dated November 23, 2015 with UNICEF to supply the BCG vaccine to UNICEF subject to the purchase orders placed with the company. It also supplies the BCG vaccine to the Ministry of Health, India pursuant to the tendering process.</p><p>The Company also supplies the BCG vaccine to Indonesia, and Nepal which are countries outside the UNICEF ambit. The Company’s BCG-ONCO for Immunotherapy drug is distributed throughout India vide commercial arrangements in India and they intend to market this immunotherapy drug in overseas jurisdictions as well. Presently, they have made several limited supplies to various countries such Lebanon, Saudi Arabia, Turkey and Switzerland.</p><p>Cut Off Price ` 80 Per Share</p><p>Mr. P. Sundaraparipooranan And Dr. P. Murali The objects of the Offer are to achieve the benefits of listing the Equity Shares on the BSE and the NSE and to carry out the sale of up to 14,579,560 Equity Shares by the Selling Shareholders. Further, the Company expects that the listing of the Equity Shares will enhance visibility and brand image among its existing and potential customers and provide liquidity to the existing shareholders. The listing of the Equity Shares will also provide a public market for the Equity Shares in India. The Company will not receive any proceeds of the Offer and all the proceeds will go to the Selling Shareholders.</p><p>There is no listed company in India whose business portfolio is comparable with that of business to be compared as a peer group company.</p><p>Disclaimer: for more details please refer RHP</p>